Joshua Bardin, MD, was already retired when a former student reached out to him about a teaching opportunity. It was 2006, and Bardin had recently traded his 26-year-long career as a vascular surgeon in San Diego for a picturesque retirement in Incline Village in Lake Tahoe.
The University of California San Diego School of Medicine celebrated its 55th Doctor of Medicine graduating class on May 31, 2026. As the new physicians crossed the stage, family and friends beamed with pride, reflecting on the years of dedication that led to this milestone moment.
New research suggests that a single administration of spinal segment-targeted gene therapy may provide a long-lasting strategy for reducing muscle spasticity caused by spinal cord injury and potentially other neurological conditions associated with abnormal muscle tone.
Red meat occupies a contested place in human diets. In a wide-ranging research review recently published in The Quarterly Review of Biology, researchers from University of California San Diego School of Medicine explore a longstanding question: Is red meat a blessing or a curse?
A study by UC San Diego researchers and their colleagues has found that semaglutide slows down the accumulation of biological aging markers in the DNA of adults with HIV, pointing to the potential of GLP‑1 receptor agonists to help prevent age‑related diseases.
U.S. overdose death rates declined between 2023 and 2024, marking the first recorded drop in all four waves of the nation’s overdose crisis. However, overdose deaths involving stimulants without fentanyl, and xylazine-related deaths, continue to rise and racial disparities remain severe.
News Channel 3, August 4
U.S. News & World Report, July 21
Technology Networks, July 17
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
